Hot Topics

Andrea Haupt
|
October 25, 2021

NIH What’s New | COVID-19 Treatment Guidelines

Andrea Haupt
|
October 25, 2021

The FDA is proposing to establish a regulatory category for over-the-counter hearing aids (Federal Register)

Andrea Haupt
|
October 25, 2021

FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines

Andrea Haupt
|
October 21, 2021

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity | FDA